Cargando…

Integrated Bioinformatic Analysis Reveals TXNRD1 as a Novel Biomarker and Potential Therapeutic Target in Idiopathic Pulmonary Arterial Hypertension

Idiopathic pulmonary arterial hypertension (IPAH) is a life-threatening cardiopulmonary disease lacking specific diagnostic markers and targeted therapy, and its mechanism of development remains to be elucidated. The present study aimed to explore novel diagnostic biomarkers and therapeutic targets...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Wenchao, Tang, Yiyang, Zhang, Mengqiu, Liang, Benhui, Wang, Meijuan, Zha, Lihuang, Yu, Zaixin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133447/ https://www.ncbi.nlm.nih.gov/pubmed/35646965 http://dx.doi.org/10.3389/fmed.2022.894584

Ejemplares similares

Corrigendum: Integrated bioinformatic analysis reveals TXNRD1 as a novel biomarker and potential therapeutic target in idiopathic pulmonary arterial hypertension
por: Lin, Wenchao, et al.
Publicado: (2022)

FUT8-Mediated Core Fucosylation Promotes the Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension
por: Zhang, Wen, et al.
Publicado: (2023)

A retrospective cohort study on the association between early coagulation disorder and short-term all-cause mortality of critically ill patients with congestive heart failure
por: Tang, Yiyang, et al.
Publicado: (2022)

Corrigendum: A retrospective cohort study on the association between early coagulation disorder and short-term all-cause mortality of critically ill patients with congestive heart failure
por: Tang, Yiyang, et al.
Publicado: (2022)

Identification of Potential Biomarkers and Immune Infiltration Characteristics in Idiopathic Pulmonary Arterial Hypertension Using Bioinformatics Analysis
por: Zeng, Haowei, et al.
Publicado: (2021)

Association of cardiac injury with hypertension in hospitalized patients with COVID-19 in China
por: Zeng, Xiaofang, et al.
Publicado: (2021)

Association between prothrombin time-international normalized ratio and prognosis of post-cardiac arrest patients: A retrospective cohort study
por: Tang, Yiyang, et al.
Publicado: (2023)

Galectin-3 Mediates Endothelial-to-Mesenchymal Transition in Pulmonary Arterial Hypertension
por: Li, Tangzhiming, et al.
Publicado: (2019)

Combination of Dichloroacetate and Atorvastatin Regulates Excessive Proliferation and Oxidative Stress in Pulmonary Arterial Hypertension Development via p38 Signaling
por: Li, Tangzhiming, et al.
Publicado: (2020)

Association of Systemic Immune-Inflammation Index With Short-Term Mortality of Congestive Heart Failure: A Retrospective Cohort Study
por: Tang, Yiyang, et al.
Publicado: (2021)

Corrigendum: Association of systemic immune-inflammation index with short-term mortality of congestive heart failure: A retrospective cohort study
por: Tang, Yiyang, et al.
Publicado: (2022)

Serum Anion Gap Is Associated with All-Cause Mortality among Critically Ill Patients with Congestive Heart Failure
por: Tang, Yiyang, et al.
Publicado: (2020)

Potential biomarkers and therapeutic targets of idiopathic pulmonary arterial hypertension
por: He, Wenjun, et al.
Publicado: (2022)

Alteration of Extracellular Superoxide Dismutase in Idiopathic Pulmonary Arterial Hypertension
por: Zhang, Rui, et al.
Publicado: (2020)

Pulmonary veno-occlusive disease in Sjogren's syndrome: a case report
por: Zeng, Xiaofang, et al.
Publicado: (2023)

Identification of diagnostic gene biomarkers related to immune infiltration in patients with idiopathic pulmonary fibrosis based on bioinformatics strategies
por: Dai, Xiangdong, et al.
Publicado: (2022)

An Overview of Circulating Pulmonary Arterial Hypertension Biomarkers
por: Santos-Gomes, Joana, et al.
Publicado: (2022)

Validity of the ESC Risk Assessment in Idiopathic Pulmonary Arterial Hypertension in China
por: Gong, Su-Gang, et al.
Publicado: (2021)

Identification of diagnostic biomarkers for idiopathic pulmonary hypertension with metabolic syndrome by bioinformatics and machine learning
por: Lu, Wenzhang, et al.
Publicado: (2023)

Prognostic Value of Gamma-Glutamyltransferase in Male Patients With Idiopathic Pulmonary Arterial Hypertension
por: Lu, Gang-Hua, et al.
Publicado: (2020)

Iron Metabolism and Idiopathic Pulmonary Arterial Hypertension: New Insights from Bioinformatic Analysis
por: Zou, Hua-Xi, et al.
Publicado: (2021)

Development and Validation of Nomogram to Predict Long-Term Prognosis of Critically Ill Patients with Acute Myocardial Infarction
por: Tang, Yiyang, et al.
Publicado: (2021)

Echocardiographic Prognosis Relevance of Attenuated Right Heart Remodeling in Idiopathic Pulmonary Arterial Hypertension
por: Zhao, Qin-Hua, et al.
Publicado: (2021)

Whole Exome Sequencing of Patients With Heritable and Idiopathic Pulmonary Arterial Hypertension in Central Taiwan
por: Liang, Kae-Woei, et al.
Publicado: (2022)

Pulmonary Arterial Stiffness: An Early and Pervasive Driver of Pulmonary Arterial Hypertension
por: Sun, Wei, et al.
Publicado: (2018)

NCAPG Promotes Pulmonary Artery Smooth Muscle Cell Proliferation as a Promising Therapeutic Target of Idiopathic Pulmonary Hypertension: Bioinformatics Analysis and Experiment Verification
por: Fu, Bowen, et al.
Publicado: (2022)

The Prognostic Impact of Serum Uric Acid on Disease Severity and 5-Year Mortality in Patients With Idiopathic Pulmonary Artery Hypertension
por: Yan, Lu, et al.
Publicado: (2022)

Inflammasome Activation in Pulmonary Arterial Hypertension
por: Foley, Anna, et al.
Publicado: (2022)

Differences in disease severity and prognosis of exercise-induced right-to-left shunt between idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension patients
por: Wang, Shang, et al.
Publicado: (2022)

Identification of Hub Genes and MicroRNAs Associated With Idiopathic Pulmonary Arterial Hypertension by Integrated Bioinformatics Analyses
por: Qiu, Xue, et al.
Publicado: (2021)

TXNRD1 Is an Unfavorable Prognostic Factor for Patients with Hepatocellular Carcinoma
por: Fu, Binsheng, et al.
Publicado: (2017)

Therapeutic Approaches for Treating Pulmonary Arterial Hypertension by Correcting Imbalanced TGF-β Superfamily Signaling
por: Andre, Patrick, et al.
Publicado: (2022)

Essential Genes and MiRNA–mRNA Network Contributing to the Pathogenesis of Idiopathic Pulmonary Arterial Hypertension
por: Hao, Shengyu, et al.
Publicado: (2021)

Identification of immune-related hub genes and analysis of infiltrated immune cells of idiopathic pulmonary artery hypertension
por: Chen, Yubin, et al.
Publicado: (2023)

Identification of autophagy-related biomarkers in patients with pulmonary arterial hypertension based on bioinformatics analysis
por: Yang, Zhisong, et al.
Publicado: (2022)

Bioinformatics analysis to identify potential biomarkers for the pulmonary artery hypertension associated with the basement membrane
por: Li, Qian, et al.
Publicado: (2023)

Serum Caveolin-1 as a Novel Biomarker in Idiopathic Pulmonary Artery Hypertension
por: Wang, Kuo-Yang, et al.
Publicado: (2015)

Apelin-17 to diagnose idiopathic pulmonary arterial hypertension: A biomarker study
por: Foris, Vasile, et al.
Publicado: (2023)

Circulating Protein Biomarkers in Systemic Sclerosis Related Pulmonary Arterial Hypertension: A Review of Published Data
por: Hickey, Peter M., et al.
Publicado: (2018)

Transcription factors in the pathogenesis of pulmonary arterial hypertension—Current knowledge and therapeutic potential
por: Körbelin, Jakob, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p9ihuj06iusoi4nagvn7rf0j8d